Does TISAGENLECLEUCEL Cause Diffuse large b-cell lymphoma recurrent? 200 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 200 reports of Diffuse large b-cell lymphoma recurrent have been filed in association with TISAGENLECLEUCEL (KYMRIAH). This represents 4.7% of all adverse event reports for TISAGENLECLEUCEL.
200
Reports of Diffuse large b-cell lymphoma recurrent with TISAGENLECLEUCEL
4.7%
of all TISAGENLECLEUCEL reports
109
Deaths
25
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma recurrent From TISAGENLECLEUCEL?
Of the 200 reports, 109 (54.5%) resulted in death, 25 (12.5%) required hospitalization, and 27 (13.5%) were considered life-threatening.
Is Diffuse large b-cell lymphoma recurrent Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TISAGENLECLEUCEL. However, 200 reports have been filed with the FAERS database.
What Other Side Effects Does TISAGENLECLEUCEL Cause?
Cytokine release syndrome (1,660)
Pyrexia (1,030)
Malignant neoplasm progression (582)
Hypotension (425)
Immune effector cell-associated neurotoxicity syndrome (416)
Neurotoxicity (411)
Platelet count decreased (397)
White blood cell count decreased (392)
Hypogammaglobulinaemia (374)
Lymphocyte count decreased (365)
What Other Drugs Cause Diffuse large b-cell lymphoma recurrent?
RITUXIMAB (1,359)
CYCLOPHOSPHAMIDE (1,007)
VINCRISTINE (957)
DOXORUBICIN (953)
PREDNISONE (738)
CYTARABINE (406)
DEXAMETHASONE (402)
ETOPOSIDE (375)
CISPLATIN (306)
GEMCITABINE (280)
Which TISAGENLECLEUCEL Alternatives Have Lower Diffuse large b-cell lymphoma recurrent Risk?
TISAGENLECLEUCEL vs TISLELIZUMAB
TISAGENLECLEUCEL vs TISOTUMAB VEDOTIN
TISAGENLECLEUCEL vs TISOTUMAB VEDOTIN-TFTV
TISAGENLECLEUCEL vs TITANIUM DIOXIDE\ZINC
TISAGENLECLEUCEL vs TIVICAY